Altamira Therapeutics Ownership | Who Owns Altamira Therapeutics?


OverviewChartTranscripts

Altamira Therapeutics Ownership Summary


Altamira Therapeutics is owned by 3.13% institutional investors, and 96.87% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in Altamira Therapeutics shares.

CYTO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAltamira Therapeutics3.13%-96.87%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202211-414,33440.62%363.22%6-14.29%3-
Jun 30, 202211-26.67%294,645-46.88%212.68%7-22.22%350.00%
Mar 31, 202215-16.67%554,714-2.09%422.89%9-2-66.67%
Dec 31, 20211812.50%566,577-15.35%416.75%9-40.00%6-
Sep 30, 202116-669,295-5-15---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index2.26K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 04, 2005SCHNITTKER CHRISTOPHER P Sr. Vice President and CFOBuy$7.86K

CYTO Ownership FAQ


Who Owns Altamira Therapeutics?

Altamira Therapeutics shareholders are primarily institutional investors at 3.13%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Altamira Therapeutics's industry, Biotech Stocks , is 44.97%, which Altamira Therapeutics falls below.

Does Blackrock own Altamira Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Altamira Therapeutics.

Who is the top mutual fund holder of Altamira Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Altamira Therapeutics shares, with 0.06% of its total shares outstanding invested in 2.26K Altamira Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools